Zero Point Five Therapeutics

Private

Baltimore, MarylandHealthcare & Life Scienceshttp://zeropointfivetherapeutics.com/

Last Round

Series C

Apr 17, 2025

Total Funding Raised

$20.2M

Company Overview

Zero Point Five Therapeutics is a biotechnology company that develops therapeutics aimed at treating soil-transmitted helminthiasis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neglected tropical diseasesNTDsoil-transmitted helminthiasisSTHsingle-dose therapybiotechnologydrug developmentclinical trialsglobal healthorphan drugspharmaceutical researchdrug discoveryparasitic disease treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zero Point Five Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Zero Point Five Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zero Point Five Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Apr 17, 2025
Series B	Jul 19, 2023
Seed	Sep 2, 2022
Series A	Feb 5, 2021

View all Funding Rounds

Zero Point Five Therapeutics Investors

Notable investors and investment history

Zero Point Five Therapeutics investors
Investor	Rounds
Next Act Fund	Series A
Portfolia	Seed, Series B, Series A
TEDCO	Series C, Seed, Series B, Series A

View all Investors

Zero Point Five Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Zero Point Five Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zero Point Five Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range2

Year Founded2018

Last FundingApr 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.